Home > Financial Ratios > WINDLAS BIOTECH

WINDLAS BIOTECH
Fixed Capital/Sales

    Back to All Ratios
WINDLAS BIOTECH is part of below Screeners ↓
Best Quarterly Growth Small Cap Stocks
Best 1M Momentum Small Cap Stocks
AD     Remove this Ad

WINDLAS BIOTECH Last 5 Year Fixed Capital/Sales History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
   Fixed Capital/Sales(x) 0.410.370.350.370.31

What is the latest Fixed Capital/Sales ratio of WINDLAS BIOTECH ?

The latest Fixed Capital/Sales ratio of WINDLAS BIOTECH is 0.41 based on Mar2025 Consolidated results.
Year Fixed Capital/Sales
Mar20250.41
Mar20240.37
Mar20230.35
Mar20220.37
Mar20210.31

How is Fixed Capital/Sales of WINDLAS BIOTECH Trending?

Years Fixed Capital/Sales % Change
Mar2025 0.41
10.81
Mar2024 0.37
5.71
Mar2023 0.35
-5.41
Mar2022 0.37
19.35
Mar2021 0.31 -

Other Financial Ratios of WINDLAS BIOTECH


Compare Fixed Capital/Sales ratio of peers of WINDLAS BIOTECH

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
WINDLAS BIOTECH ₹1,787.5 Cr 7.7% 8.9% -14.8% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹382,694.0 Cr -2.3% -7.3% -12.8% Stock Analytics
DIVIS LABORATORIES ₹160,721.0 Cr 0.8% -5.8% 4.7% Stock Analytics
TORRENT PHARMACEUTICALS ₹134,016.0 Cr 0.8% 3.7% 20.8% Stock Analytics
CIPLA ₹106,946.0 Cr 0.7% -11.2% -6.5% Stock Analytics
DR REDDYS LABORATORIES ₹101,691.0 Cr -1.4% -3.8% -1.3% Stock Analytics


WINDLAS BIOTECH Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
WINDLAS BIOTECH

7.7%

8.9%

-14.8%

SENSEX

-0.1%

-2.9%

7.5%


You may also like the below Video Courses